arrow
arrow
arrow
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
Question

In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:

A.

Retroviral vector is introduced into these lymphocytes.

B.

Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages

C.

Lymphocytes from patient's blood are grown in culture, outside the body.

D.

Genetically engineered lymphocytes are not immortal cells.

Correct option is D

Free Tests

Free
Must Attempt

NBTS 2024 Full Syllabus 01

languageIcon English
  • pdpQsnIcon200 Questions
  • pdpsheetsIcon720 Marks
  • timerIcon200 Mins
languageIcon English
Free
Must Attempt

Samarthan Test Series : Complete Class 11th + 12th Syllabus Full Syllabus 01

languageIcon English
  • pdpQsnIcon200 Questions
  • pdpsheetsIcon720 Marks
  • timerIcon200 Mins
languageIcon English